Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$319M |
| 2 |
GSK
GSK
|
+$230M |
| 3 |
LO
LORILLARD INC COM STK
LO
|
+$192M |
| 4 |
Verizon
VZ
|
+$174M |
| 5 |
Mastercard
MA
|
+$160M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.08B |
| 2 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$850M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$781M |
| 4 |
Bausch Health
BHC
|
+$466M |
| 5 |
Meta Platforms (Facebook)
META
|
+$407M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 7.58% |
| 2 | Technology | 5.48% |
| 3 | Financials | 4.9% |
| 4 | Energy | 3.61% |
| 5 | Consumer Discretionary | 3.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4851
PUT
KBR
KBR
$4.81B
| $78K | ﹤0.01% |
5,600
-33,000
| -85% | -$537K |
|
4852
PUT
Liberty Global Class C
LBTYK
$3.43B
| $78K | ﹤0.01% |
1,978
-17,800
| -90% | -$705K |
|
4853
Mine Safety
MSA
$7.42B
| $78K | ﹤0.01% |
1,592
-4,020
| -72% | -$194K |
|
|
CSC
4854
CALL
DELISTED
Computer Sciences
CSC
| $78K | ﹤0.01% |
2,848
-8,305
| -74% | -$229K |
|
|
POM
4855
CALL
DELISTED
PEPCO HOLDINGS, INC.
POM
| $78K | ﹤0.01% |
3,000
+1,500
| +100% | +$40.7K |
|
4856
PUT
ProShares Ultra Technology
ROM
$1.29B
| $77K | ﹤0.01% |
16,000
+3,200
| +25% | +$15.4K |
|
4857
PUT
Teradyne
TER
$57.9B
| $77K | ﹤0.01% |
4,300
-2,800
| -39% | -$53.6K |
|
|
SPA
4858
DELISTED
Sparton
SPA
| $77K | ﹤0.01% |
3,247
-1,061
| -25% | -$25.4K |
|
4859
Acacia Research
ACTG
$467M
| $76K | ﹤0.01% |
7,601
-1,142
| -13% | -$14.9K |
|
4860
Align Technology
ALGN
$12.3B
| $76K | ﹤0.01% |
1,430
+550
| +63% | +$31.3K |
|
|
CALY
4861
Callaway Golf Company
CALY
$3.13B
| $76K | ﹤0.01% |
8,398
-5,605
| -40% | -$47.7K |
|
4862
PUT
Plug Power
PLUG
$3.03B
| $76K | ﹤0.01% |
37,900
-94,800
| -71% | -$275K |
|
|
AJRD
4863
PUT
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $76K | ﹤0.01% |
3,300
+3,000
| +1,000% | +$57.9K |
|
|
SN
4864
DELISTED
Sanchez Energy Corporation
SN
| $76K | ﹤0.01% |
5,913
-2,994
| -34% | -$36.6K |
|
4865
Celldex Therapeutics
CLDX
$3.28B
| $75K | ﹤0.01% |
186
-2,713
| -94% | -$971K |
|
4866
iShares Russell Mid-Cap Value ETF
IWS
$15.9B
| $75K | ﹤0.01% |
1,000
| – | – |
|
4867
Precigen
PGEN
$2.58B
| $75K | ﹤0.01% |
1,746
-138,321
| -99% | -$4.97M |
|
4868
Telus
TU
$15B
| $75K | ﹤0.01% |
4,564
-47,574
| -91% | -$823K |
|
4869
Vanguard Financials ETF
VFH
$13.8B
| $75K | ﹤0.01% |
1,528
+1,128
| +282% | +$55.2K |
|
|
SNMX
4870
DELISTED
Senomyx, Inc.
SNMX
| $75K | ﹤0.01% |
18,816
+1,439
| +8% | +$7.54K |
|
|
PVTB
4871
DELISTED
PrivateBancorp Inc
PVTB
| $75K | ﹤0.01% |
2,148
-1,995
| -48% | -$67.4K |
|
4872
PUT
Adtran
ADTN
$655M
| $74K | ﹤0.01% |
4,100
-1,300
| -24% | -$27.6K |
|
4873
Charles River Laboratories
CRL
$12.7B
| $74K | ﹤0.01% |
932
-1,261
| -58% | -$93K |
|
4874
FuelCell Energy
FCEL
$1.6B
| $74K | ﹤0.01% |
17
+7
| +70% | +$38.8K |
|
4875
Griffon
GFF
$4.67B
| $74K | ﹤0.01% |
4,322
-1,247
| -22% | -$19.2K |
|
Similar funds
Barclays's Q1 2015 Portfolio in Review
As of Q1 2015, Barclays held 7,637 positions worth $86.7B, down 17% from $104B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays withdrew a net $19.4B in Q1 2015, closing 488 positions and reducing 4,377 holdings. Its most notable exit was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019, an estimated $781M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 5.7% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in iPath Pure Beta Broad Commodity ETN worth $55.8M.
- Barclays's largest Q1 2015 buy was iPath Pure Beta Broad Commodity ETN: 1,861,500 shares worth $55.8M.
- Barclays added most to Envision Healthcare Holdings Inc in Q1 2015, an estimated $319M increase.
- Barclays's biggest Q1 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.08B.
- Barclays fully exited iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019 in Q1 2015, selling an estimated $781M.
- Barclays's ten largest holdings make up 25% of its $86.7B portfolio in Q1 2015.
- Barclays opened 330 new positions and closed 488 in Q1 2015.
- Barclays's portfolio value fell 17% quarter-over-quarter to $86.7B.
Based on Barclays's 13F filing for Q1 2015, filed 14 May 2015.